Together, the intra-tumor T-cell phenotype upon CEA-TCB and anti-PD-L1 combination treatment is reflective of T-cells having higher propensity for recruitment and putatively lower exhaustion status, and may reflect a higher recruitment of fresh T-cells from the peripheral blood. The gene discussed is CEACAM5; the disease is neoplasm.